author-photo

Ajay K. Kakkar

Queen Mary University of London

197

Papers

22819

Citations

Citation Trend

Filter By

Papers (197) Sort By

Journal Conference Others

GARFIELD-AF risk score for mortality, stroke and bleeding within 2 years in patients with atrial fibrillation.

2021
Show All
- Source
- Cite
- Save
Citations (0)
PO-36 Treatment of cancer-associated venous thromboembolism: 12-month outcomes of the placebo versus rivaroxaban randomisation of the SELECT-D trial

2021 Thrombosis Research
Show All
- Source
- Cite
- Save
Citations (0)
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry.

2021 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (1)
Management strategies and clinical outcomes in patients with inferior vena cava thrombosis: Data from GARFIELD-VTE

2021 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (0)
The Importance of the Design of Observational Studies in Comparative Effectiveness Research: Lessons from the GARFIELD-AF and ORBIT-AF registries.

2021 American Heart Journal
Show All
- Source
- Cite
- Save
Citations (0)
The influence of Anemia on clinical outcomes in venous thromboembolism: Results from GARFIELD-VTE

2021 Thrombosis Research
Show All
- Source
- Cite
- Save
Citations (0)
Influence of body mass index on clinical outcomes in venous thromboembolism: Insights from GARFIELD-VTE.

2021 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (0)
Middle East Treatment Strategies and Clinical Outcomes in Patients with Atrial Fibrillation: One-Year Follow-up Data from Garfield-AF Study.

2021 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (0)
Cardioversion in patients with newly diagnosed non-valvular atrial fibrillation: observational study using prospectively collected registry data.

2021 BMJ
Show All
- Source
- Cite
- Save
Citations (0)
Treatment of Cancer‐Associated Venous Thromboembolism: 12‐month outcomes of the placebo versus rivaroxaban randomisation of the SELECT‐D Trial. (SELECT‐D: 12m)

2020 Journal of Thrombosis and Haemostasis
Show All
- Source
- Cite
- Save
Citations (21)